Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

Expressive Writing Boosts College Students' Health, New Study Finds
NewsApr 19, 2026

Expressive Writing Boosts College Students' Health, New Study Finds

Research led by James Pennebaker asked college students to journal about their deepest emotions for 15 minutes a day over three days. Months later the participants visited doctors far less and showed stronger immune markers than a control group. The...

By Pulse
New Synthetic Opioid Shows Lower Addiction Risk Than Morphine in Rodent Study
NewsApr 19, 2026

New Synthetic Opioid Shows Lower Addiction Risk Than Morphine in Rodent Study

Researchers at the National Institute on Drug Abuse reported that DFNZ, a novel nitazene‑derived opioid, produced weaker withdrawal symptoms and less compulsive self‑administration than morphine in rats, hinting at a safer pain‑relief alternative.

By Pulse
Curing U.S. Health Care, Part I
BlogApr 19, 2026

Curing U.S. Health Care, Part I

The Affordable Care Act, enacted in 2010 and fully implemented by 2014, expanded coverage to millions of Americans and slowed the growth of national health‑spending. Yet by 2024, roughly 8% of the population remains uninsured, and a larger share is...

By Paul Krugman
10x Genomics Unveils Atera Platform for Whole‑Transcriptome Spatial Biology
NewsApr 19, 2026

10x Genomics Unveils Atera Platform for Whole‑Transcriptome Spatial Biology

10x Genomics announced Atera, a new in situ spatial biology platform that delivers whole‑transcriptome analysis at single‑cell resolution and scale. Debuted at the AACR 2026 meeting, the technology aims to reshape disease research and clinical diagnostics by removing trade‑offs between...

By Pulse
CDC Reports Record Tick‑Bite ER Visits: 71 per 100,000, Double Average
NewsApr 19, 2026

CDC Reports Record Tick‑Bite ER Visits: 71 per 100,000, Double Average

The Centers for Disease Control and Prevention said emergency rooms saw 71 tick‑bite visits per 100,000 patients in the second week of April, more than double the typical 30‑per‑100,000 rate and matching the peak seen in 2017. The surge is...

By Pulse
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
NewsApr 19, 2026

20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs

The U.S. priority review voucher (PRV) program, created in 2007 to spur drug development for neglected tropical diseases (NTDs), has turned into a lucrative market incentive, with vouchers fetching nine‑figure sums. A landmark case is MDGH’s moxidectin, the first new...

By Forbes – Healthcare
Pitt Researchers Leverage Big‑Data Model to Forecast Texas Measles Outbreak
NewsApr 19, 2026

Pitt Researchers Leverage Big‑Data Model to Forecast Texas Measles Outbreak

University of Pittsburgh public‑health scientists deployed the FRED big‑data simulation to map a 2025 measles surge that infected more than 800 Texans and killed two children. The model’s granular forecasts helped state officials target vaccination campaigns and curb the outbreak’s...

By Pulse
Trump Signs Order to Fast‑track Ibogaine and Other Psychedelics
NewsApr 19, 2026

Trump Signs Order to Fast‑track Ibogaine and Other Psychedelics

President Donald Trump signed an executive order to accelerate the FDA’s review of ibogaine and other psychedelic drugs, citing potential relief for veterans with PTSD and opioid addiction. The move includes priority vouchers that could cut review times from months...

By Pulse
A Closer Look at Body Composition in Obesity Drug Trials
BlogApr 19, 2026

A Closer Look at Body Composition in Obesity Drug Trials

A new systematic review of 36 randomized controlled trials, published in Annals of Internal Medicine, reveals that obesity medications often cause a sizable loss of lean mass. In 65% of drug trials, more than a quarter of total weight loss...

By ConscienHealth
Exercise, IADL, Social Interaction Ease Depression in Elderly
NewsApr 19, 2026

Exercise, IADL, Social Interaction Ease Depression in Elderly

A 2026 BMC Geriatrics study by Zhao and Huang shows that regular physical exercise significantly reduces depressive symptoms among older Chinese adults. The benefit is strongest for seniors with higher instrumental activities of daily living (IADL) functional status, indicating that...

By Bioengineer.org
Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole
PodcastApr 19, 20260 min

Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole

In this episode of American Sunrise, chief scientific officer Dr. Peter McCullough discusses a new wellness‑company study showing that the antiparasitic drugs ivermectin and mebendazole, when used alongside standard cancer therapies, yielded an 84% positive net clinical benefit in over 200...

By FOCAL POINTS (Courageous Discourse)
Weekly Reads: Prasad Successor, Sammy Hagar Stem Cells, More on OSK Trial, Finnish Speaker Needed
BlogApr 19, 2026

Weekly Reads: Prasad Successor, Sammy Hagar Stem Cells, More on OSK Trial, Finnish Speaker Needed

Vinay Prasad is set to leave his role as head of the FDA's Center for Biologics Evaluation and Research (CBER within two weeks, prompting speculation about the agency’s future direction. A new flexible oversight framework for rare‑disease gene and cell therapies...

By The Niche
STAT+: The Race to Catch KRAS, Pancreatic Cancer’s ‘Greasy Ball,’ and Create the Most Promising Drug in Decades
NewsApr 19, 2026

STAT+: The Race to Catch KRAS, Pancreatic Cancer’s ‘Greasy Ball,’ and Create the Most Promising Drug in Decades

A new wave of KRAS‑targeted therapies is reshaping pancreatic cancer treatment after decades of failure. Revolution Medicines’ daraxonrasib, a next‑generation KRAS inhibitor, delivered dramatic survival benefits for patient Leanna Stokes, who enrolled in a clinical trial. The drug’s success has...

By STAT (Biotech)
CMS Just Moved $13 Billion in Medicare Advantage Payments. Here's What Healthcare Investors Need to Know.
BlogApr 19, 2026

CMS Just Moved $13 Billion in Medicare Advantage Payments. Here's What Healthcare Investors Need to Know.

CMS announced a 2.48% Medicare Advantage rate increase for 2027, adding roughly $13 billion in federal payments. The agency also froze the risk‑adjustment model, reversing a proposed -3.32% recalibration that would have erased most growth. Simultaneously, CMS eliminated 11 Star Ratings...

By HealthVC
The Next Chemical Cage Has a Beautiful Door
BlogApr 19, 2026

The Next Chemical Cage Has a Beautiful Door

President Biden signed an executive order fast‑tracking psychedelic drugs, granting the FDA priority vouchers for serotonin‑2A agonists. The move follows a public ceremony with Joe Rogan, RFK Jr., and FDA Commissioner Marty Makary, signaling a shift from traditional plant‑based use to pharmaceutical...

By Radically Genuine
Senate Committee Calls Out Kennedy’s Vaccine Lies
SocialApr 19, 2026

Senate Committee Calls Out Kennedy’s Vaccine Lies

@SecKennedy addresses the Senate HELP committee this week. The evidence is clear that @SecKennedy lied during his confirmation hearing, kept lying, & continues to lie about his extremist anti-vaccine beliefs & the deaths he’s already caused. Thank you, Sen. Alsobrooks,...

By Angela Rasmussen
NHS Locking Patients Out: A Growing Concern
SocialApr 19, 2026

NHS Locking Patients Out: A Growing Concern

Just listen to this by @michaelsearles_ for how the NHS is locking patients out. So worrying: https://t.co/WuAOpyH8mx

By Laura Donnelly
Quirky China: Doctor Removes Worm From Woman’s Brain, Under-Fire Gamer Dyes Her Skin Black
NewsApr 19, 2026

Quirky China: Doctor Removes Worm From Woman’s Brain, Under-Fire Gamer Dyes Her Skin Black

Surgeons in Guangdong, China, successfully removed an 8 cm-long parasitic worm from the brain of a 61‑year‑old woman who had endured years of numbness and unexplained symptoms. The woman traced the infection to a childhood folk remedy where a frog’s leg...

By South China Morning Post — Economy
Financial Strain of Non-Communicable Diseases in Indian Elderly
NewsApr 19, 2026

Financial Strain of Non-Communicable Diseases in Indian Elderly

A new mixed‑methods study by Prince and Kodali published in BMC Geriatrics quantifies the financial burden of non‑communicable diseases on Indian households with older adults. The research combines survey data and interviews, revealing that out‑of‑pocket medical expenses, asset sales, and...

By Bioengineer.org
Stanbic IBTC Pension Managers Takes CRS to Federal Neuropsychiatric Hospital, Enugu
NewsApr 19, 2026

Stanbic IBTC Pension Managers Takes CRS to Federal Neuropsychiatric Hospital, Enugu

Stanbic IBTC Pension Managers completed a comprehensive renovation of the Federal Neuropsychiatric Hospital in Enugu, upgrading both exterior landscaping and interior patient wards. The project added a 20‑meter security fence, a new borehole, modernized plumbing, new furniture, and refurbished six...

By BusinessDay (Nigeria)
Chinese Biotech's Global Surge May Hinge on AI
SocialApr 19, 2026

Chinese Biotech's Global Surge May Hinge on AI

China’s drug makers are speeding up – will AI be their secret weapon? Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next level? No "overcapacity" here.... https://t.co/sktFORaVey via @scmpnews

By Paul Triolo
HCWs Have Died and Been Disabled. Laws Should Have Prevented This
NewsApr 19, 2026

HCWs Have Died and Been Disabled. Laws Should Have Prevented This

Healthcare workers (HCWs) across North America have suffered severe COVID‑19 infections, long‑COVID disability, and deaths despite existing occupational health and safety (OHS) laws. The article highlights how reliance on surgical masks—designed as splash guards, not respirators—left staff exposed to airborne...

By The Good Men Project
10x Genomics Unveils Atera Spatial Platform at AACR Meeting
NewsApr 19, 2026

10x Genomics Unveils Atera Spatial Platform at AACR Meeting

10x Genomics announced the Atera spatial platform at the AACR meeting, promising whole‑transcriptome spatial profiling at scale. The instrument delivers four times the throughput, six times the plex capacity, and up to three‑fold higher sensitivity compared with the company’s Xenium...

By GEN (Genetic Engineering & Biotechnology News)
Violence Against Women Fuels Kenya’s HIV Crisis
NewsApr 19, 2026

Violence Against Women Fuels Kenya’s HIV Crisis

Sexual and gender‑based violence is fueling Kenya’s HIV epidemic, especially among adolescent girls and young women. New UNAIDS data show that 4,000 girls worldwide acquire HIV each week, with 3,300 in sub‑Saharan Africa, and Kenya reports 44‑55 new female infections...

By Daily Nation (Kenya) – Business
Congress Pushes Telehealth and Accessibility Bills That Could Reshape HR Tech Compliance
NewsApr 19, 2026

Congress Pushes Telehealth and Accessibility Bills That Could Reshape HR Tech Compliance

Republican and Democratic lawmakers introduced the Tech to Save Moms Act and a bipartisan update to the 21st Century Communications and Video Accessibility Act. The measures aim to expand telehealth for maternal care and modernize video‑communication standards, forcing HR‑tech vendors...

By Pulse
Doctori.com Deploys AI Assistant to Cut Health‑Insurance Costs by Up to 30%
NewsApr 19, 2026

Doctori.com Deploys AI Assistant to Cut Health‑Insurance Costs by Up to 30%

Doctori.com unveiled an AI‑driven assistant that guides Spanish consumers through health‑insurance selection, promising 25‑30% premium savings. The tool compares over 90 products across 10,000 tariff variations, marking the first AI‑based recommendation engine in the market.

By Pulse
Forbion Crowned Europe’s Largest Independent VC, Targets Asian Expansion
NewsApr 19, 2026

Forbion Crowned Europe’s Largest Independent VC, Targets Asian Expansion

Forbion has been named Europe’s largest independent venture capital firm and, in the same announcement, unveiled a plan to seek new life‑science investments across Asia. Managing Partner Sander Slootweg said the move aims to offset funding constraints in Europe and...

By Pulse
CDC: Antibiotic Resistant Shigella Becoming Higher Risk in US
BlogApr 19, 2026

CDC: Antibiotic Resistant Shigella Becoming Higher Risk in US

The CDC’s latest analysis shows a sharp rise in extensively drug‑resistant (XDR) Shigella infections in the United States, climbing from 0% of isolates in 2011‑2015 to 8.5% in 2023. Of the 510 XDR isolates identified, two‑thirds were Shigella sonnei and...

By Marler Blog
HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP‑1 Medications
BlogApr 19, 2026

HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP‑1 Medications

At the ASRA annual meeting, Hospital for Special Surgery researchers presented two studies on peri‑operative management of patients taking GLP‑1 agonists. A multicenter ultrasound assessment of 354 elective surgery patients found no statistically significant difference in full‑stomach incidence between GLP‑1...

By HealthTech HotSpot
Monash IVF Singapore Spotlights Male Factor Infertility for National Infertility Awareness Week (NIAW)
NewsApr 19, 2026

Monash IVF Singapore Spotlights Male Factor Infertility for National Infertility Awareness Week (NIAW)

Monash IVF Singapore is using National Infertility Awareness Week to highlight male factor infertility, which contributes to roughly half of all infertility cases. The clinic is rolling out a digital education series to demystify male reproductive health and encourage early...

By The Manila Times – Business
Teva's $40 Target: Olanzapine, Specialty Drugs and Biosimilars Fuel Upside
NewsApr 19, 2026

Teva's $40 Target: Olanzapine, Specialty Drugs and Biosimilars Fuel Upside

Teva Pharmaceutical Industries' stock has surged 130% in the past year, and analysts see three catalysts—FDA approval of a long‑acting olanzapine, accelerating specialty‑drug sales, and a wave of biosimilar launches—that could push the share price past $40. The outlook rests...

By Pulse
MyLGHealth Launches Free AI Lab‑report Reader, No Funding Needed
NewsApr 19, 2026

MyLGHealth Launches Free AI Lab‑report Reader, No Funding Needed

MyLGHealth rolled out a free, doctor‑trained AI platform that reads lab reports and prescriptions in plain language without charging users or storing data. The tool, launched amid a wave of venture‑backed health‑AI startups, aims to close the health‑literacy gap affecting...

By Pulse
Three Israeli Strikes Kill Four Paramedics in Southern Lebanon
NewsApr 19, 2026

Three Israeli Strikes Kill Four Paramedics in Southern Lebanon

Three Israeli strikes on ambulances in the Lebanese village of Mayfadoun killed four paramedics and wounded six others. The attacks, captured on a GoPro video, have sparked condemnation from the UN and renewed concerns about the targeting of health workers...

By Pulse
India Claims Spot as World’s No.2 in Applied Nanotech, Says Lt Governor
NewsApr 19, 2026

India Claims Spot as World’s No.2 in Applied Nanotech, Says Lt Governor

At the inaugural session of the International Conference on Nanotechnology for Better Living (NBL‑2025), Lieutenant Governor Manoj Sinha announced that India now ranks second worldwide, after China, in converting nanotech research into commercial applications. He urged greater investment in mission‑driven...

By Pulse
Quality Metrics for Drug Manufacturing
NewsApr 19, 2026

Quality Metrics for Drug Manufacturing

The FDA is advancing a Quality Metrics Reporting Program to collect objective manufacturing data from drug producers. By analyzing these metrics, the agency aims to enhance risk‑based surveillance, predict shortages, and streamline inspections. The initiative builds on a decade of...

By FDA
Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
NewsApr 18, 2026

Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments

Definium Therapeutics welcomed the White House’s new executive order that aims to speed research, regulatory review, and access to innovative mental‑health treatments, including psychedelics. The order directs federal agencies to streamline pathways and boost cross‑agency collaboration. Definium highlighted its DT120...

By Financial Post
Three Gene Therapy Pioneers Just Won the Breakthrough Prize. This Is Their Story
NewsApr 18, 2026

Three Gene Therapy Pioneers Just Won the Breakthrough Prize. This Is Their Story

Three pioneering scientists—Jean Bennett, Albert Maguire, and David J. Wilson—have been honored with the 2026 Breakthrough Prize in Life Sciences for their work on Luxturna, the first gene‑therapy approved by the U.S. Food and Drug Administration. Luxturna treats a rare...

By Endpoints News
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
BlogApr 18, 2026

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Compass Pathways welcomed the White House Executive Order aimed at speeding up research and access to psychedelic therapies for serious mental illness. The biotech highlighted its COMP360 synthetic psilocybin, which has delivered statistically significant results in two Phase 3 trials for...

By HealthTech HotSpot
What Are Psychedelic Drugs?
NewsApr 18, 2026

What Are Psychedelic Drugs?

Psychedelic substances such as LSD, psilocybin, DMT and mescaline produce hallucinations and altered perception, yet they are generally non‑addictive. Recent FDA draft guidance released in June 2023 seeks to standardize clinical research into their therapeutic potential for mental‑health disorders like depression,...

By Verywell Mind
Extrapyramidal Side Effects From Medication
NewsApr 18, 2026

Extrapyramidal Side Effects From Medication

Extrapyramidal side effects (EPS) are movement‑related disorders that arise primarily from dopamine‑blocking antipsychotics, especially first‑generation agents. Common manifestations include akathisia, dystonia, drug‑induced parkinsonism, tardive dyskinesia, and the rare but serious neuroleptic malignant syndrome. Prevalence varies widely—akathisia affects roughly 19.5% of...

By Verywell Mind
Fauci And CDC Proven Wrong As Massive Denmark Study Shows Masks And Vaccines Failed To Stop COVID
BlogApr 18, 2026

Fauci And CDC Proven Wrong As Massive Denmark Study Shows Masks And Vaccines Failed To Stop COVID

The blog post argues that masks and COVID‑19 vaccines failed to curb the pandemic, citing a large Danish study as evidence. It quotes Anthony Fauci and former CDC chief Rochelle Walensky asserting that vaccines, masks, tests and antivirals were the "tools"...

By Unmasked
Sidewinder Cuts DNA Assembly Errors to One‑in‑Million
SocialApr 18, 2026

Sidewinder Cuts DNA Assembly Errors to One‑in‑Million

Biology's source code is DNA. For 40 years, we've been able to read it. Writing it, especially long, complex sequences, is still painfully slow, expensive, and error-prone. Current DNA assembly methods fail about once every 10 to 30 connections. Kaihang Wang's lab...

By John Cumbers
Custom 3D‑Printed Hydrogel Electrodes Boost Neural Signal Quality
SocialApr 18, 2026

Custom 3D‑Printed Hydrogel Electrodes Boost Neural Signal Quality

3D-printed hydrogel electrodes tailored to individual brain structures offer improved fit and signal quality for neural monitoring, potentially advancing personalized approaches to neurodegenerative disease management. neurotechnology

By Phys.org Threads
Wastewater Detects Drug-Resistant Candidozyma Auris Emergence
NewsApr 18, 2026

Wastewater Detects Drug-Resistant Candidozyma Auris Emergence

Researchers published a Nature Communications study showing that wastewater‑based epidemiology can identify drug‑resistant Candida auris in hospitals weeks before patients test positive. By extracting fungal DNA from sewage and applying metagenomic sequencing plus quantitative PCR, the team quantified pathogen load...

By Bioengineer.org
Amgen's Potts Lab Unveils Universal Molecular Glue Platform
SocialApr 18, 2026

Amgen's Potts Lab Unveils Universal Molecular Glue Platform

Next up #aacr26 is @pottslab from Amgen discussing their broad and diverse molecular glue & degrader platform “any target, every time” https://t.co/SfJ0jGYene

By Sally Church
Funding Global Cancer Research to Cure Every Patient
SocialApr 18, 2026

Funding Global Cancer Research to Cure Every Patient

EVERY CANCER. EVERY PATIENT. EVERYWHERE. @ConquerCancerFd of the American Society of Clinical Oncology (@ASCO) raises funds to support the world's leading researchers who are improving treatments & discovering cures for patients around the world. https://t.co/du6r6gdsgV #ASCO26

By Mike Thompson, MD PhD
Medical Schools Commit to Boost Nutrition Training for Doctors
SocialApr 18, 2026

Medical Schools Commit to Boost Nutrition Training for Doctors

FACT SHEET: Secretary Kennedy and Secretary McMahon Celebrate Medical School Commitments to Increase Nutrition Training for Future Doctors https://t.co/mLHvkJhPkB

By David Barzilai, MD PhD
DepMap's Future: PRMT5 Inhibitor Differences Unveiled
SocialApr 18, 2026

DepMap's Future: PRMT5 Inhibitor Differences Unveiled

Excellent talk from Bill Sellers on future directions with DepMap. Interesting differences between different PRMT5 inhibitors (SAM & MTA) and how they compare with selective inhibitors #aacr26 https://t.co/xfmKVqEpp1

By Sally Church
Pro‑vaccine CDC
SocialApr 18, 2026

Pro‑vaccine CDC

That selecting a physician who understands the importance of vaccines and immunizations is treated as an act of “MAHA betrayal,” likely reflects its payola from corrupt the wellness influencers. If indeed this was the President’s decision, then he did the...

By Peter Hotez